3-deoxyglucosone has been researched along with glucagon-like peptide 1 in 4 studies
| Studies (3-deoxyglucosone) | Trials (3-deoxyglucosone) | Recent Studies (post-2010) (3-deoxyglucosone) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
|---|---|---|---|---|---|
| 186 | 8 | 77 | 9,484 | 1,208 | 6,374 |
| Protein | Taxonomy | 3-deoxyglucosone (IC50) | glucagon-like peptide 1 (IC50) |
|---|---|---|---|
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, G; Liang, G; Song, X; Wang, F; Xu, H; Zhang, L; Zhou, L | 1 |
| Huang, F; Jiang, G; Liang, G; Song, X; Wang, F; Zhang, L; Zhou, L | 1 |
| Huang, F; Jiang, G; Liang, G; Song, X; Wang, F; Xu, H; Zhang, L; Zhou, L | 1 |
| Huang, F; Jiang, G; Liang, G; Shi, M; Song, X; Wang, F; Zhang, L; Zhou, L | 1 |
4 other study(ies) available for 3-deoxyglucosone and glucagon-like peptide 1
| Article | Year |
|---|---|
Acute Reduction of Incretin Effect and Glucose Intolerance in Rats by Single Intragastric Administration of 3-deoxyglucosone.
Topics: Animals; Cyclic AMP; Deoxyglucose; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Incretins; Insulin; Male; Mice; Prediabetic State; Rats | 2017 |
The downregulation of sweet taste receptor signaling in enteroendocrine L-cells mediates 3-deoxyglucosone-induced attenuation of high glucose-stimulated GLP-1 secretion.
Topics: Animals; Benzene Derivatives; Blotting, Western; Cell Line; Cyclic AMP; Deoxyglucose; Dietary Sugars; Down-Regulation; Enteroendocrine Cells; Enzyme-Linked Immunosorbent Assay; Glucagon-Like Peptide 1; Glucose; Intestinal Secretions; Mice; Osmolar Concentration; Protein Subunits; Receptors, G-Protein-Coupled; Second Messenger Systems; TRPM Cation Channels | 2018 |
3-Deoxyglucosone interferes with insulin signaling and attenuates insulin action on glucose-induced GLP-1 secretion in the enteroendocrine L cell line STC-1.
Topics: Animals; Cell Line; Deoxyglucose; Enteroendocrine Cells; Glucagon-Like Peptide 1; Glucose; Glucose Transporter Type 2; Insulin; Mice; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Signal Transduction | 2019 |
3-Deoxyglucosone reduces glucagon-like peptide-1 secretion at low glucose levels through down-regulation of SGLT1 expression in STC-1 cells.
Topics: Animals; Cells, Cultured; Cyclic AMP; Deoxyglucose; Enteroendocrine Cells; Glucagon-Like Peptide 1; Glucose; Insulin; Intestine, Small; Mice; Sodium-Glucose Transporter 1 | 2021 |